Aptevo Therapeutics's total assets for Q2 2025 were $15.62M, an increase of 87.29% from the previous quarter. APVO total liabilities were $9.10M for the fiscal quarter, a -7.28% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.